References
- Ljungberg B, Hanbury D, Kuczyk M, et al. Guidelines on renal cell carcinoma. March 2009 update. EAU, 2009. Available at: http://www.uroweb.org/fileadmin/user_upload/Guidelines/08_Renal_Cell_Carcinoma_2007.pdf [Last accessed 15 January 2010]
- Mickisch G, Carballido J, Hellsten S, et al. Guidelines on renal cell cancer. Eur Urol 2001;40:232-55
- Gupta K, Miller J, Li J, et al. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Canc Treat Rev 2008;34:193-205
- Lineham W, Zbar B. Focus on kidney cancer. Cancer Cell 2004;6:223-8
- Motzer R, Mazamunder M, Becik J, et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 1999;17:2530-40
- National Institute for Clinical Excellence. Improving Outcomes in Urological Cancers. London: NICE, 2002
- Coppin C, Portzolt F, Kumpf J, et al. Immunotherapy for advanced renal cell carcinoma. Cochrane Database Sys Rev 2005;1:CD001425
- Poppel H. Treatment of advanced metastatic renal cancer: a revolution?. Eur Urol Suppl 2009;8:483-8
- Motzer R, Hutson T, Tomczak P, et al. Sunitib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356:115-24
- Rini B, McDermott D, Atkins M. What is the standard initial systemic therapy in metastatic renal cell carcinoma?. Clin Genitourinary Cancer 2007;5:256-63
- Vogelzang N. Treatment options in metastatic renal cell carcinoma: an embarrassment of riches. J Clin Oncol 2006;24:1-3
- Motzer RJ, Hutson TE, Tomczak P, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 2009;27:3584-90
- Hudes GR, Berkenblit A, Feingold J, et al. Clinical trial experience with temsirolimus in patients with advanced renal cell carcinoma. Semin Oncol 2009;36(s3):s26-36
- Deeks E, Keating G. Sunitib. Drugs 2006;66:2255-66
- Belmut J, Guix M. The medical management of metastatic renal cell carcinoma: integrating new guidelines and recommendations. Br J Urol 2009;103:572-7
- Litwin M, Fine J, Dorey F, et al. Health related quality of life outcomes in patients treated for metastatic kidney cancer: A pilot study. J Urol 1997;157:1608-12
- National Institute for Clinical Excellence. Guide to Methods of Technology Appraisal. London: NICE, 2004
- Fojo T, Grady C. How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question. J Natl Cancer Inst 2009;101:1044-8
- Torrance G. Measurement of health state utilities for economic appraisal. J Health Econ 1986;5:1-30
- Belmut J. Sunitib in advanced renal cell carcinoma: clinical evidence. Eur J Cancer Suppl 2007;5:12-19
- Cella D, Li J, Joseph C, et al. Quality of life in patients with metastatic renal cell carcinoma treated with sunitib or interferon alpha: results from a phase III randomized trial. J Clin Oncol 2008;26:3763-9
- Lloyd A, Nafees B, Narewska J, et al. Health state utilities for metastatic breast cancer. Br J Cancer 2006;95:683-90
- Nafees B, Stafford M, Gavriel S. Health state utilities for non small cell lung cancer. Health Qual Life Outcomes 2008;6:84
- Brooks R. EuroQol: the current state of play. Health Policy 1996;7:53-72
- Office of National Statistics. Population of the United Kingdom: By Ethnic Group. National Statistics website, 2001. Available at http://www.statistics.gov.uk/CCI/nugget.asp?ID=273 [Last accessed 15 January 2010]
- Kind P, Dolan P, Gudex C, et al. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998;316:736-41
- Department of Health. End of Life Care Strategy: Promoting High Quality Care for All Adults at the End of Life. Gateway ref 2840, 2008
- Department of Health. High Quality Care for All. NHS Next Stage Final Review Report. CM 7432, 2008
- Towse A. Should NICE's threshold range for cost per QALY range be raised? YES. BMJ 2009;338:b181
- National Institute for Clinical Excellence. Supplementary Advice to the Appraisal Committees: Appraising Life-Extending, End of Life Treatments. London: NICE, 2009